|
Symbol |
Object Name |
Qualifiers |
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
GW 501516 results in increased expression of ABCA1 mRNA; GW 501516 results in increased expression of ABCA1 protein |
CTD |
PMID:19201410 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abhd3 |
abhydrolase domain containing 3, phospholipase |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of ABHD3 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of ACADM mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of ACADVL mRNA |
CTD |
PMID:16197558 |
|
NCBI chr10:55,231,558...55,236,786
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
ISO |
GW 501516 results in increased expression of ACOX1 mRNA |
CTD |
PMID:16574099 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions increases expression |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of ANGPTL4 mRNA GW 501516 results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:16197558 PMID:34627044 |
|
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions |
ISO |
GW 501516 promotes the reaction [APOA1 protein results in increased secretion of Lipids] |
CTD |
PMID:19201410 |
|
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of GCH1 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD1 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD3 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased phosphorylation of NOS3 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased susceptibility to Acetylcholine]; GW 501516 inhibits the reaction [APP gene mutant form results in increased abundance of 7,8-dihydrobiopterin]; GW 501516 inhibits the reaction [APP gene mutant form results in increased chemical synthesis of Superoxides]; GW 501516 inhibits the reaction [APP gene mutant form results in increased expression of CYBB protein]; GW 501516 inhibits the reaction [APP gene mutant form results in increased oxidation of and results in decreased abundance of sapropterin] |
CTD |
PMID:22886847 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bcl6 |
BCL6, transcription repressor |
multiple interactions |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] |
CTD |
PMID:23737761 |
|
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] GW 501516 inhibits the reaction [Palmitates results in increased expression of CCL2 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] GW 501516 results in decreased expression of CCL2 mRNA |
CTD |
PMID:16574099 PMID:21966476 PMID:23737761 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of CEBPA mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions increases expression |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of CPT1A mRNA GW 501516 results in increased expression of CPT1A mRNA |
CTD |
PMID:16197558 PMID:16574099 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
multiple interactions increases expression |
EXP |
RELA protein inhibits the reaction [GW 501516 results in increased expression of CPT1B mRNA] |
CTD |
PMID:18701451 |
|
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
decreases expression |
ISO |
GW 501516 results in decreased expression of CX3CR1 mRNA |
CTD |
PMID:19850645 |
|
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
GW 501516 inhibits the reaction [APP gene mutant form results in increased expression of CYBB protein] |
CTD |
PMID:22886847 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
GW 501516 inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] |
CTD |
PMID:19667161 |
|
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of DDIT4 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of ECH1 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression multiple interactions |
ISO |
GW 501516 results in increased expression of FABP1 mRNA [GW 501516 binds to PPARD protein] which results in increased expression of FABP1 mRNA |
CTD |
PMID:16197558 PMID:16574099 |
|
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
multiple interactions |
ISO |
GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of GCH1 protein] |
CTD |
PMID:22886847 |
|
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of HADHA mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of HMGCS2 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of HSDL2 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] |
CTD |
PMID:23737761 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA] GW 501516 results in decreased expression of IL1B mRNA |
CTD |
PMID:16574099 PMID:23737761 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases expression |
ISO |
GW 501516 results in decreased expression of IL6 mRNA |
CTD |
PMID:16574099 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kiz |
kizuna centrosomal protein |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of KIZ mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 3:154,730,873...154,838,410
Ensembl chr 3:134,277,687...134,385,190
|
|
G |
Lipc |
lipase C, hepatic type |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of LIPC mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
EXP |
MDM2 protein inhibits the reaction [GW 501516 results in increased activity of PPARB protein] |
CTD |
PMID:19103650 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; PPARD mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] |
CTD |
PMID:23737761 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of NEDD9 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity |
ISO |
GW 501516 results in increased activity of NFE2L2 protein |
CTD |
PMID:30114225 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
GW 501516 results in decreased expression of NFKB1 mRNA |
CTD |
PMID:16574099 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
GW 501516 inhibits the reaction [APP gene mutant form results in decreased phosphorylation of NOS3 protein] |
CTD |
PMID:22886847 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
[GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:18701451 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP |
[GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] |
CTD |
PMID:18701451 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
increases expression |
ISO |
GW 501516 results in increased expression of NR1H2 mRNA |
CTD |
PMID:19201410 |
|
NCBI chr 1:104,178,483...104,183,863
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression multiple interactions affects response to substance |
ISO |
GW 501516 results in increased expression of NR1H3 mRNA NR1H3 protein affects the reaction [GW 501516 results in increased expression of PPARA mRNA] NR1H3 protein affects the susceptibility to GW 501516 |
CTD |
PMID:19201410 |
|
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
GW 501516 promotes the reaction [Indomethacin results in increased cleavage of PARP1 protein] |
CTD |
PMID:21400612 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of PCK1 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression |
ISO |
GW 501516 results in increased expression of PDK4 mRNA |
CTD |
PMID:34627044 |
|
NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of PDZK1 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Plin2 |
perilipin 2 |
multiple interactions increases expression |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of PLIN2 mRNA; PPARD mutant form inhibits the reaction [GW 501516 results in increased expression of PLIN2 mRNA] |
CTD |
PMID:16197558 PMID:23737761 |
|
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Pltp |
phospholipid transfer protein |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of PLTP mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:153,574,825...153,592,647
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions affects binding increases expression affects response to substance |
ISO |
[Calcitriol co-treated with GW 501516] results in increased expression of PPARA mRNA; NR1H3 protein affects the reaction [GW 501516 results in increased expression of PPARA mRNA] GW 501516 binds to PPARA protein PPARA protein affects the susceptibility to GW 501516 |
CTD |
PMID:19201410 PMID:19667161 PMID:23843199 PMID:25689681 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
affects binding increases activity multiple interactions increases expression |
ISO EXP |
GW 501516 binds to PPARB protein; GW 501516 binds to PPARD protein GW 501516 results in increased activity of PPARB protein [Calcitriol co-treated with GW 501516] results in increased expression of PPARD mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ABHD3 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ACADM mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ACADVL mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ANGPTL4 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of CEBPA mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of CPT1A mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of DDIT4 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ECH1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of FABP1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of HADHA mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of HMGCS2 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of HSDL2 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of KIZ mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of LIPC mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of NEDD9 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PCK1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PDZK1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PLIN2 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PLTP mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of RNU7-65P mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SERPINE1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SLC22A7 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SLC30A10 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SULT2A1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of TRIB2 mRNA; GW 501516 binds to and results in increased activity of PPARD protein; GW 501516 promotes the reaction [PPARD protein results in increased expression of SIRT1 mRNA]; PPARD mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; PPARD mutant form inhibits the reaction [GW 501516 results in increased expression of PLIN2 mRNA] [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; MDM2 protein inhibits the reaction [GW 501516 results in increased activity of PPARB protein] GW 501516 results in increased activity of PPARD protein GW 501516 results in increased expression of PPARD mRNA 4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 501516 results in increased expression of PPARD mRNA]; [GW 501516 co-treated with PPARD protein] results in increased expression of PPARGC1A mRNA; GW 501516 binds to and results in increased activity of PPARD protein |
CTD |
PMID:16197558 PMID:17275789 PMID:18292206 PMID:18701451 PMID:19103650 PMID:19201410 PMID:19667161 PMID:20160399 PMID:20516370 PMID:21966476 PMID:23391484 PMID:23737761 PMID:23843199 PMID:27551952 PMID:30033591 PMID:32407875 PMID:34627044 More...
|
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression increases activity |
ISO |
GW 501516 results in increased expression of PPARG mRNA GW 501516 results in increased activity of PPARG protein |
CTD |
PMID:16386710 PMID:19201410 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions increases expression |
ISO |
[GW 501516 co-treated with PPARD protein] results in increased expression of PPARGC1A mRNA GW 501516 results in increased expression of PPARGC1A mRNA |
CTD |
PMID:17275789 PMID:23056435 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
cannabidiolic acid inhibits the reaction [GW 501516 results in increased expression of PTGS2 mRNA] |
CTD |
PMID:32238697 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
[GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein]; RELA protein inhibits the reaction [GW 501516 results in increased expression of CPT1B mRNA] |
CTD |
PMID:18701451 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA] |
CTD |
PMID:23737761 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of SERPINE1 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
GW 501516 promotes the reaction [PPARD protein results in increased expression of SIRT1 mRNA] |
CTD |
PMID:20160399 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of SLC22A7 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc30a10 |
solute carrier family 30, member 10 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of SLC30A10 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr13:99,529,664...99,584,442
Ensembl chr13:96,998,143...97,009,103
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD1 protein] |
CTD |
PMID:22886847 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
ISO |
GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD3 protein] |
CTD |
PMID:22886847 |
|
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
decreases activity |
ISO |
GW 501516 results in decreased activity of STAT5B protein |
CTD |
PMID:30114225 |
|
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of SULT2A1 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 1:84,582,011...84,639,001
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
ISO |
GW 501516 results in decreased expression of TGFB1 mRNA |
CTD |
PMID:16574099 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; PPARD mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] GW 501516 results in decreased expression of TNF mRNA |
CTD |
PMID:16574099 PMID:21966476 PMID:23737761 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trib2 |
tribbles pseudokinase 2 |
multiple interactions |
ISO |
[GW 501516 binds to PPARD protein] which results in increased expression of TRIB2 mRNA |
CTD |
PMID:16197558 |
|
NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:38,545,975...38,569,370
|
|
G |
Ucp2 |
uncoupling protein 2 |
increases expression |
EXP |
GW 501516 results in increased expression of UCP2 mRNA |
CTD |
PMID:16239165 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] |
CTD |
PMID:23737761 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vdr |
vitamin D receptor |
increases expression multiple interactions |
ISO |
GW 501516 results in increased expression of VDR mRNA [Calcitriol co-treated with GW 501516] results in increased expression of VDR mRNA |
CTD |
PMID:19667161 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
|
|